Diabetes and Endocrinology
Home Diabetes and Endocrinology
Flatter Diurnal Cortisol Slopes Linked to Poorer Health Outcomes
Flatter diurnal cortisol slopes tied to poorer health in 10 of 12 subtypes of emotional, physical health
mAb Glucagon Receptor Blocker Suitable for Further Development
REGN1193 inhibited glucose increase stimulated by glucagon in dose-dependent manner
Strong Religious Beliefs May Be Linked to Higher Weight
Some health behaviors, psychosocial factors mediate religion-weight relationship
Ipragliflozin Beneficial in T2DM Complicated by Liver Disease
Effect similar to pioglitazone, with reduction in body weight, abdominal fat only for ipragliflozin
Similar Defects ID’d for T2DM, Chronic Pancreatitis and Diabetes
Similarly disturbed α-cell responses to oral glucose ingestion and hypoglycemia
Canagliflozin Delays Increase in Certain CV Biomarkers in T2DM
Canagliflozin may reduce CV, heart failure risk over two years versus placebo in older patients with T2DM
Revenue Exceeds Expenditures for Many ABMS Member Boards
Change in net balance of American Board of Medical Specialties member boards grew from 2003 to 2013
July 2017 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for July 2017. This roundup includes...
Poor Adherence to Self-Monitoring of Glucose in GDM
Poor adherence tied to preeclampsia; poor post-prandial test timing tied to higher HbA1c at delivery
New Research Supports Safety of Aspirin in Heart Failure
Large trial comparing it to warfarin finds aspirin not tied to more hospitalizations or deaths
